Related Experiment Video
Updated: May 21, 2026
09:59
Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity
Published on: March 31, 2023
Targeting cancer stem cells with ALDH1A1-based immunotherapy
1University of Pittsburgh Cancer Institute and Department of Pathology; School of Medicine; University of Pittsburgh; Pittsburgh, PA USA.
Oncoimmunology
|June 28, 2012
Summary
Aldehyde dehydrogenase (ALDH) bright cells exhibit cancer stem cell (CSC) traits. ALDH1A1-specific CD8(+) T cells recognize these CSCs, indicating potential for ALDH1A1-based immunotherapy.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Aldehyde dehydrogenase (ALDH) bright cells are recognized as cancer stem cells (CSCs) across various human tumor models.
- These CSCs possess unique biological characteristics that drive tumor initiation and progression.
Purpose of the Study:
- To investigate the immunogenicity of ALDH bright CSCs.
- To determine if ALDH1A1-specific CD8(+) T cells can recognize and target CSCs.
Main Methods:
- Analysis of ALDH expression in human tumor cell lines, xenografts, and lesions.
- In vitro and in vivo studies using ALDH1A1-specific CD8(+) T cells to assess recognition of ALDH bright cells.
Main Results:
- ALDH bright cells consistently displayed CSC characteristics in the studied models.
- ALDH1A1-specific CD8(+) T cells demonstrated the ability to recognize ALDH bright CSCs both in vitro and in vivo.
Conclusions:
- ALDH1A1 is a potential target antigen for CSCs.
- ALDH1A1-based immunotherapy holds promise for specifically targeting cancer stem cells.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...